CIK 0001412408
- Large accelerated filer
Phreesia, Inc.
Sign in to watch- Ticker
- PHR
- Exchange
- NYSE
- Industry
- Services-Business Services, NEC
- FY end
- Jan 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 888-654-7473
- Business address
- 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803
- Former names
- Phreesia Inc
- Open-market buys, last 90 days
- $683
- in 1 filing
- Open-market sales, last 90 days
- $67,153
- in 1 filing, $67K under 10b5-1 plans
Net −$66,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-16 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −2,011 | $23.81 | $48K | 219,727 |
| 2025-04-16 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −2,488 | $23.66 | $59K | 217,239 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −2,410 | $23.46 | $57K | 223,272 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −1,534 | $24.48 | $38K | 221,738 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −152 | $23.46 | $4K | 9,108 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −96 | $24.48 | $2K | 9,012 |
| 2025-04-04 | Linetsky David SVP, Life Sciences | Grant or award | +6,432 | 225,682 | ||
| 2025-04-04 | Linetsky David SVP, Life Sciences | Grant or award | +536 | 9,260 | ||
| 2025-03-19 | Linetsky David SVP, Life Sciences | Sale | −81 | $27.85 | $2K | 8,731 |
| 2025-03-19 | Linetsky David SVP, Life Sciences | Sale | −7 | $28.31 | $198 | 8,724 |
| 2025-03-18 | Linetsky David SVP, Life Sciences | Sale | −39 | $26.95 | $1K | 8,812 |
| 2025-02-13 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −11,616 | $29.70 | $345K | 218,135 |
| 2025-02-07 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −300 | $29.52 | $9K | 229,751 |
| 2025-02-05 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −720 | $29.50 | $21K | 230,051 |
| 2023-12-18 | Linetsky David SVP, Life Sciences | Sale | −100 | $23.15 | $2K | 9,904 |
| 2022-12-15 | Linetsky David SVP, Life Sciences | Sale | −22 | $34.01 | $748 | 9,770 |
| 2022-09-15 | Linetsky David SVP, Life Sciences | Grant or award | +1,392 | $28.72 | $40K | 9,792 |
| 2020-02-21 | Linetsky David SVP, Life Sciences | Exercise or conversion | +3,413 | $0.73 | $2K | 219,250 |
| 2020-02-21 | Linetsky David SVP, Life Sciences | Exercise or conversion · Stock Option (Right to Buy) | −3,413 | 0 |
Page 3 of 3 · 59 trades